Facebook Linkedin RSS Twitter Youtube
Home 2024

Drug development (Pharmacology)

Nirrin Launches Atlas for At-Line Analysis at the Point of Sampling
Bioprocessing

Nirrin Launches Atlas for At-Line Analysis at the Point of Sampling

Creating Consistency and Confidence for Biopharma Companies
Bioprocessing

Creating Consistency and Confidence for Biopharma Companies

Pan-Cancer Proteogenomics Unlocks New Therapeutic Targets and Insights
Cancer

Pan-Cancer Proteogenomics Unlocks New Therapeutic Targets and Insights

Abzena Partners with Argonaut to Offer Drug Development and Manufacturing Support for Biopharma Companies
Bioprocessing

Abzena Partners with Argonaut to Offer Drug Development and Manufacturing Support for Biopharma Companies

Sibylla Biotech and MD Anderson Agree to Jointly Discover and Develop Small-Molecule Protein Degraders
Drug Discovery

Sibylla Biotech and MD Anderson Agree to Jointly Discover and Develop Small-Molecule Protein Degraders

Fluorescent Minibody Tracer Helps Surgeons Detect Prostate Cancer Cells during Surgery
Cancer

Fluorescent Minibody Tracer Helps Surgeons Detect Prostate Cancer Cells during Surgery

Machine Learning Digs Up a Treasure Trove of Antimicrobial Peptides
Artificial Intelligence

Machine Learning Digs Up a Treasure Trove of Antimicrobial Peptides

Finding “Impossible” Antibodies in the Human Body
Drug Discovery

Finding “Impossible” Antibodies in the Human Body

Evolving Trends in Pharmaceuticals
Drug Discovery

Evolving Trends in Pharmaceuticals

Mitigating Risks in Oligonucleotide Therapeutic Development
Sponsored

Mitigating Risks in Oligonucleotide Therapeutic Development

123...165Page 1 of 165
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.